Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05756244 · ClinicalTrials.gov registry record
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
A clinical trial of Pregnancy Related and Venous Thromboembolism, sponsored by University of Calgary.
- Recruiting
- Registry status
- 825
- Enrollment target
- 14
- Study locations
NCT05756244: Recruiting study of Pregnancy Related and Venous Thromboembolism, sponsored by University of Calgary.
NCT05756244 is a study of Pregnancy Related and Venous Thromboembolism that is actively recruiting participants, run by University of Calgary. The registered enrollment target is 825 participants, below the 1,955-participant average among 99 other Pregnancy Related trials with a reported enrollment target (58% lower). The trial reports 14 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05756244, a study of Pregnancy Related and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Calgary.
- RECRUITING
- Registry status
- 825 participants
- Enrollment target
- 14
- Study locations
Study Summary
The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.
Primary Outcome
To estimate the combined incidence of major bleeding (MB) and clinically relevant non-major bleeding (CRNMB) for the six most common antepartum strategies.
Conditions Studied
Study Locations (14)
Ontario
- McMaster University Medical Centre - Hamilton
- The Ottawa Hospital - General Campus - Ottawa
- Montfort Hospital - Ottawa
- Mount Sinai Hospital - Toronto
Other
- Aarhus University Hospital - Aarhus
- Le Centre Hospitalier Universitaire of Saint-Etienne - Saint-Etienne
- Hopitaux universitaires de Geneve - Geneva
Alberta
- Foothills Medical Centre - Calgary
- Royal Alexandra Hospital - Edmonton
Quebec
- CHU Sainte-Justine - Montreal
- The Sir Mortimer B. Davis Jewish General Hospital - Montreal
North Carolina
- Duke University Hospital - Durham
British Columbia
- BC Women's Hospital and Health Centre - Vancouver
Manitoba
- St. Boniface Hospital - Winnipeg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2029-12-31 |
What NCT05756244 shows while recruiting
NCT05756244 is an observational study that tracks outcomes without assigning an intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, below the 1,955-participant average among 99 other Pregnancy Related trials with a reported enrollment target (58% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.
NCT05756244 lists 14 locations in 7 states (Ontario, Other, Alberta).
Frequently Asked Questions
What is clinical trial NCT05756244 about?
NCT05756244 is a clinical study titled "PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism". The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.
What is the current status of trial NCT05756244?
This trial is currently recruiting. The enrollment target is 825 participants. The study started on 2023-04-04. Estimated completion is 2029-12-31.
What conditions does trial NCT05756244 study?
This clinical trial studies the following conditions: Pregnancy Related, Venous Thromboembolism.
Who is sponsoring clinical trial NCT05756244?
This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05756244 being conducted?
This trial has 14 study locations across North Carolina, Alberta, British Columbia, Manitoba, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05756244's enrollment target sits among peer trials
825 21st of 99 higher than 79 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT07318077 · 825 participants · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI